By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Nattermannallee 1/S20

Cologne    50829  Germany
Phone: 49-221-998818-0 Fax: 49-221-998818-10



Company News
Luxcel Biosciences , Axiogenesis And BMG LABTECH GmbH Secure €2.5m European Investment To Develop And Launch Cell Metabolism Analysis Platform: "Metacell-TM" 2/15/2017 6:51:35 AM
Axiogenesis And Metrion Biosciences Announce Stem Cell Collaboration 11/7/2016 9:52:26 AM
Axiogenesis Secures Major Funding For Its Expansion Course 5/3/2016 11:05:06 AM
Axiogenesis Signs Sublicensing Agreement For Cellular Assay Patents With GE Healthcare 7/14/2015 10:19:22 AM
Axiogenesis Earns U.S. Patent With In Vitro Drug Discovery Assay for Hypertrophic Cardiomyopathy 12/4/2012 10:52:10 AM
Sigma(R) Life Science and Axiogenesis Collaborate to Market More Predictive iPSC-Based Assays and Services for Preclinical Cardiotoxicity Screening 7/31/2012 9:55:54 AM
Axiogenesis In-Licenses Yamanaka Patent Portfolio from iPS Academia Japan, Inc. Covering Induced Pluripotent Stem Cell Technology 8/3/2010 8:31:30 AM
Roche (RHHBY) (JOBS) and Axiogenesis Enter into Co-Development and Marketing Agreement 12/9/2008 6:33:14 AM
ReachBio LLC Partners with Axiogenesis to Distribute Novel Cell-Based Products in North America 2/27/2008 7:09:35 AM